| 1/16 | US=22 / Câncer Stein CA, Benimerskaya L, Kornblum NS, Mani S. Antisense agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 522-7. MECANISMOS DE ACAO; MELANOMA AVANCADA; SEGURANCA E TOLERABILIDADE |
| 2/16 | US=4 / Cirurgia Silberman H, Iqbal S. Gastric cancer: perioperative adjunctive therapy. In: Silberman H, Silberman AW. Principles and practice of surgical oncology: a multidisciplinary approach to difficult problems. Philadelphia: J B Lippincott, 2010. p. 661-75. ISBN 978-0-7817-6546-6. CANCER; ONCOLOGIA CIRURGICA; CANCER GASTRICO; TRATAMENTO ADJUVANTE PERIOPERATORIO; QUIMIOTERAPIA SISTEMICA ADJUVANTE; QUIMIOTERAPIA INTRAPERITONEAL ADJUVANTE; RADIOTERAPIA ADJUVANTE; QUIMIOIRRADIACAO ADJUVANTE; QUIMIOIMUNOTERAPIA ADJUVANTE; TERAPIA NEOADJUVANTE; TERAPIA COMBINADA; EXAMES PRE-CLINICOS; EXAMES LABORATORIAIS; MODULACAO DA ANGIOGENESE TUMORAL; TERAPIA ANTISENSE |
| 3/16 | US=87 / Biol/Mol Luttges J, Hahn SA, Heidenblut AM. Manual microdissection combined with antisense RNA-longSage for the analysis of limited cell numbers. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 135-54. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3. MICRODISSECCAO; AMPLIFICACAO DO RNA; T7 RNA POLIMERASE; AMPLIFICADO ARN ANTI-SENTIDO; ARNA; ARNA-LONGSAGE; PERFIS DE EXPRESSAO |
| 4/16 | US=89 / Biol/Mol Devi GR. Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 351-61. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. ENTREGA DE OLIGOMEROS; PHOSPHORODIAMIDATE MORFOLINO; CANCER; APOPTOSE; FLUORESCENCIA; IMUNOMARCACOES; OLIGONUCLEOTIDEOS; PMO |
| 5/16 | US=108 / Câncer Moss C, Lemoine N. RNA interference and dominant negative approaches. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 241-54. ISBN 978-0-470-01922-1. RNA DE INTERFERENCIA; AGENTES OLIGONUCLEOTIDEOS; RNAI; ANTISENSE |
| 6/16 | US=103 / Câncer Khan H, Missailidis S. Antisense agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 317-30. ISBN 978-0-470-72303-6. AGENTES ANTI-SENTIDO; OLIGONUCLEOTIDOS ANTI-SENTIDO; RIBOZIMAS; DNAZIMAS; RNA DE INTERFERENCIA; SIRNA |
| 7/16 | US=39 / Câncer Förster Y, Schwenzer B. Antisense oligonucleotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potential. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 337-62. ISBN 978-1-58829-989-5. OLIGONUCLEOTIDOS ANTI-SENTIDO; SIRNA COMO INIBIDORES ESPECIFICOS; EXPRESSAO DO GENE; MECANISMOS DE ACAO; POTENCIAL TERAPEUTICO |
| 8/16 | US=65 / Biol/Mol D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8. RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE |
| 9/16 | US=67 / Biol/Mol Gupta A, Kirkwood JM. Melanoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 343-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MELANOMA; PATOGENESE MOLECULAR; TERAPIA ALVO; INTERFERON; STAT; ANTISENSE BC12; BRAF; APOPTOSE; CICLO CELULAR |
| 10/16 | US=67 / Biol/Mol Vogl DT, Gewirtz AM. Nucleic acid therapies for cancer treatment. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 413-29. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER. TERAPIA; ACIDO NUCLEICO; OLIGONUCLEOTIDEOS ANTISENSE; DNA; RNAI |
| 11/16 | US=84-A / Biol/Mol Schlingensiepen KH, Jachimczak P, Fischer-Blass B, Fischer D, Specht H, schmaus S, Schlingensiepen R. Development of inhibitors of transforming growth factor-B signaling for therapy: targeted downregulation of TGF-B2 with AP 12009 in tumor therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 635-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. OLIGODEOXINUCLEOTIDOS ANTISENSE; CANCER; GLIOMA MALIGNO; TGF-B; USO TERAPEUTICO |
| 12/16 | US=107 / Câncer Boulikas T, Alevizopoulos N, Ladopoulou A, Belimezi M, Pantos A, Christofis P, Roberts M. Anticancer therapeutics. In: Missailidis S, editor. The cancer clock. New Jersey: John Wiley & Sons, 2007. p. 172-218. ISBN 978-0-470-06151-0. CANCER; PROBLEMAS NO CANCER; CANCER. TRATAMENTO; TERAPEUTICAS ANTICANCER; DROGAS DE PLATINA; AGENTES ANTIMICROTUBULO; ANTIMETABOLITOS; ANTIBIOTICOS ANTITUMORAIS; AGENTES ALQUILANTES; CICLO CELULAR E CANCER; APOITOSIS E CANCER; ANGIOGENESE E CANCER; IMUNOTERAPIA DO CANCER; TERAPIA GENETICA; RNAI; ANTISENSE; CELULAS CANCEROSAS; APTAMEROS |
| 13/16 | US=76 / Biol/Mol Narayanan R. Bioinformatics approaches to cancer gene discovery. In: Sioud M. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 13-31. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. BIOINFORMATICA. GENE DO CANCER; ANTISENSE; SINDROME DE DOWN; GENOMICA; TUMORES SOLIDOS |
| 14/16 | US=4 / Biol/Mol Léo P, Martins AKA. Transferência de genes em células de mamíferos: transfecção. In: Peres CM, Curi R. Como cultivar células. Rio de Janeiro: Guanabara-Koogan, 2005. p. 173-87. ISBN 85-2770975-9. TRANSFECCAO; SISTEMAS DE TRANSFECCAO; VETORES; METODOS DE TRANSFECCAO; ELETROPORACAO; TRANSFECCAO MEDIADA POR LISSOMO; TRANSFECCAO COM FOSFATO DE CALCIO; MARCADORES DE SELECAO; FARMACOCINETICA DOS OLIGOS ANTISENSE; CAPTACAO CELULAR; MECANISMO DE ACAO |
| 15/16 | US=139 / Tese/FAP Silva APM. Caraterização de genes diferencialmente expressos em linhagens celulares de mama que expressam diferentes níveis de C-erbB2. [Effects of photobiomodulation in the immunity of patients with oral mucositis]. São Paulo, 2006. 163 p. Tese(Doutorado)-Fundação Antônio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2006/APMSilva/APMSilva.pdf CANCER DE MAMA; CROMOSSOMO 17; PERFIL DA EXPRESSAO GENICA; GENE C-ERBB2; ONCOGENES |
| 16/16 | US=267 / Tese/FAP Vidal DO. Identificação em larga escala de transcritos antisenso e genes com expressão alélica diferencial utilizando bancos de dados de SAGE E MPSS. [High-throughput identification of natural antisense transcripts and genes displaying allelic differential expression using SAGE and MPSS databases]. São Paulo, 2009. 107 p. Tese(Doutorado)-Fundação Antônio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2009/DVidal/DVidal.pdf EXPRESSAO GENICA; GENES; TRANSCRITOS ANTISENSO; EXPRESSAO ALELICA DIFERENCIAL; SAGE; MPSS |
